Annual EBIT:
-$503.01M-$34.44M(-7.35%)Summary
- As of today, CYTK annual earnings before interest & taxes is -$503.01 million, with the most recent change of -$34.44 million (-7.35%) on December 31, 2024.
- During the last 3 years, CYTK annual EBIT has fallen by -$317.03 million (-170.46%).
- CYTK annual EBIT is now -2103.80% below its all-time high of $25.10 million, reached on December 31, 2009.
Performance
CYTK EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$166.75M-$55.25M(-49.55%)Summary
- As of today, CYTK quarterly earnings before interest & taxes is -$166.75 million, with the most recent change of -$55.25 million (-49.55%) on September 30, 2025.
- Over the past year, CYTK quarterly EBIT has dropped by -$25.95 million (-18.43%).
- CYTK quarterly EBIT is now -389.50% below its all-time high of $57.60 million, reached on June 30, 2009.
Performance
CYTK Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$572.93M-$25.95M(-4.74%)Summary
- As of today, CYTK TTM earnings before interest & taxes is -$572.93 million, with the most recent change of -$25.95 million (-4.74%) on September 30, 2025.
- Over the past year, CYTK TTM EBIT has dropped by -$48.31 million (-9.21%).
- CYTK TTM EBIT is now -2197.81% below its all-time high of $27.31 million, reached on September 30, 2009.
Performance
CYTK TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CYTK EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -7.3% | -18.4% | -9.2% |
| 3Y3 Years | -170.5% | -53.8% | -161.8% |
| 5Y5 Years | -433.2% | -3316.7% | -605.2% |
CYTK EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -170.5% | at low | -53.8% | at low | -161.8% | at low |
| 5Y | 5-Year | -467.6% | at low | -3316.7% | at low | -605.2% | at low |
| All-Time | All-Time | -2103.8% | at low | -389.5% | at low | -2197.8% | at low |
CYTK EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$166.75M(-49.5%) | -$572.93M(-4.7%) |
| Jun 2025 | - | -$111.51M(+28.4%) | -$546.98M(+3.3%) |
| Mar 2025 | - | -$155.63M(-11.9%) | -$565.64M(-5.5%) |
| Dec 2024 | -$503.01M(-7.3%) | -$139.04M(+1.3%) | -$536.25M(-2.2%) |
| Sep 2024 | - | -$140.80M(-8.2%) | -$524.63M(-3.7%) |
| Jun 2024 | - | -$130.17M(-3.1%) | -$506.09M(-1.6%) |
| Mar 2024 | - | -$126.23M(+0.9%) | -$497.97M(-0.4%) |
| Dec 2023 | -$468.58M(-38.7%) | -$127.42M(-4.2%) | -$496.20M(-0.1%) |
| Sep 2023 | - | -$122.27M(-0.2%) | -$495.82M(-2.9%) |
| Jun 2023 | - | -$122.05M(+1.9%) | -$481.99M(-30.0%) |
| Mar 2023 | - | -$124.47M(+2.0%) | -$370.82M(-14.4%) |
| Dec 2022 | -$337.80M(-81.6%) | -$127.03M(-17.1%) | -$324.20M(-48.1%) |
| Sep 2022 | - | -$108.44M(-897.3%) | -$218.88M(-21.8%) |
| Jun 2022 | - | -$10.87M(+86.0%) | -$179.64M(+19.6%) |
| Mar 2022 | - | -$77.86M(-258.7%) | -$223.56M(-20.0%) |
| Dec 2021 | -$185.98M(-109.9%) | -$21.70M(+68.6%) | -$186.31M(+7.3%) |
| Sep 2021 | - | -$69.20M(-26.3%) | -$201.02M(-58.7%) |
| Jun 2021 | - | -$54.80M(-34.9%) | -$126.63M(-21.5%) |
| Mar 2021 | - | -$40.61M(-11.5%) | -$104.19M(-10.9%) |
| Dec 2020 | -$88.61M(+6.1%) | -$36.41M(-802.3%) | -$93.94M(-15.6%) |
| Sep 2020 | - | $5.18M(+116.0%) | -$81.24M(+26.4%) |
| Jun 2020 | - | -$32.36M(-6.6%) | -$110.35M(-5.4%) |
| Mar 2020 | - | -$30.36M(-28.1%) | -$104.71M(-5.9%) |
| Dec 2019 | -$94.33M(-11.3%) | -$23.71M(+0.9%) | -$98.87M(-2.3%) |
| Sep 2019 | - | -$23.93M(+10.4%) | -$96.62M(-6.6%) |
| Jun 2019 | - | -$26.72M(-9.0%) | -$90.61M(-3.8%) |
| Mar 2019 | - | -$24.52M(-14.3%) | -$87.30M(+1.8%) |
| Dec 2018 | -$84.72M(+23.5%) | -$21.46M(-19.8%) | -$88.92M(+14.5%) |
| Sep 2018 | - | -$17.91M(+23.5%) | -$103.98M(+9.2%) |
| Jun 2018 | - | -$23.41M(+10.4%) | -$114.50M(+1.5%) |
| Mar 2018 | - | -$26.13M(+28.5%) | -$116.28M(-2.5%) |
| Dec 2017 | -$110.79M(-678.5%) | -$36.53M(-28.5%) | -$113.40M(-63.9%) |
| Sep 2017 | - | -$28.42M(-12.8%) | -$69.18M(-918.6%) |
| Jun 2017 | - | -$25.19M(-8.4%) | -$6.79M(-334.9%) |
| Mar 2017 | - | -$23.25M(-402.4%) | $2.89M(-79.6%) |
| Dec 2016 | $19.15M(+151.4%) | $7.69M(-77.4%) | $14.19M(+662.8%) |
| Sep 2016 | - | $33.97M(+319.0%) | -$2.52M(+94.4%) |
| Jun 2016 | - | -$15.51M(-29.8%) | -$45.37M(-12.2%) |
| Mar 2016 | - | -$11.95M(-32.5%) | -$40.45M(-8.1%) |
| Dec 2015 | -$37.23M(-154.2%) | -$9.02M(-1.5%) | -$37.41M(-87.4%) |
| Sep 2015 | - | -$8.89M(+16.1%) | -$19.96M(-16.9%) |
| Jun 2015 | - | -$10.59M(-18.9%) | -$17.07M(-14.7%) |
| Mar 2015 | - | -$8.91M(-205.8%) | -$14.89M(-0.9%) |
| Dec 2014 | -$14.65M(+56.6%) | $8.42M(+240.4%) | -$14.75M(+11.9%) |
| Sep 2014 | - | -$6.00M(+28.7%) | -$16.74M(+28.3%) |
| Jun 2014 | - | -$8.41M(+4.1%) | -$23.36M(+22.2%) |
| Mar 2014 | - | -$8.77M(-236.3%) | -$30.02M(+11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$33.72M(+16.5%) | $6.43M(+151.0%) | -$33.89M(+34.6%) |
| Sep 2013 | - | -$12.61M(+16.3%) | -$51.81M(-5.1%) |
| Jun 2013 | - | -$15.07M(-19.1%) | -$49.28M(-14.1%) |
| Mar 2013 | - | -$12.65M(-10.1%) | -$43.18M(-6.6%) |
| Dec 2012 | -$40.37M(+15.6%) | -$11.49M(-14.0%) | -$40.51M(-2.0%) |
| Sep 2012 | - | -$10.07M(-12.3%) | -$39.73M(+1.5%) |
| Jun 2012 | - | -$8.97M(+10.1%) | -$40.32M(+10.4%) |
| Mar 2012 | - | -$9.98M(+6.8%) | -$45.00M(+3.8%) |
| Dec 2011 | -$47.82M(+3.0%) | -$10.71M(-0.3%) | -$46.77M(+1.9%) |
| Sep 2011 | - | -$10.67M(+21.8%) | -$47.70M(+3.8%) |
| Jun 2011 | - | -$13.65M(-16.1%) | -$49.60M(-1.0%) |
| Mar 2011 | - | -$11.75M(-1.0%) | -$49.10M(+1.1%) |
| Dec 2010 | -$49.30M(-296.4%) | -$11.63M(+7.4%) | -$49.63M(+1.5%) |
| Sep 2010 | - | -$12.56M(+4.5%) | -$50.40M(-9.4%) |
| Jun 2010 | - | -$13.15M(-7.1%) | -$46.07M(-286.6%) |
| Mar 2010 | - | -$12.28M(+0.9%) | $24.69M(-5.3%) |
| Dec 2009 | $25.10M(+144.9%) | -$12.40M(-50.7%) | $26.07M(-4.5%) |
| Sep 2009 | - | -$8.23M(-114.3%) | $27.31M(+28.1%) |
| Jun 2009 | - | $57.60M(+628.4%) | $21.32M(+140.8%) |
| Mar 2009 | - | -$10.90M(+2.3%) | -$52.32M(+7.6%) |
| Dec 2008 | -$55.88M(+1.1%) | -$11.16M(+21.5%) | -$56.61M(+6.3%) |
| Sep 2008 | - | -$14.22M(+11.3%) | -$60.41M(-1.7%) |
| Jun 2008 | - | -$16.04M(-5.6%) | -$59.39M(-2.5%) |
| Mar 2008 | - | -$15.19M(-1.5%) | -$57.91M(-2.5%) |
| Dec 2007 | -$56.49M(+7.9%) | -$14.96M(-13.3%) | -$56.49M(+3.5%) |
| Sep 2007 | - | -$13.20M(+9.4%) | -$58.51M(+4.6%) |
| Jun 2007 | - | -$14.56M(-5.8%) | -$61.31M(+0.5%) |
| Mar 2007 | - | -$13.76M(+18.9%) | -$61.63M(-0.5%) |
| Dec 2006 | -$61.34M(-37.4%) | -$16.98M(-6.1%) | -$61.34M(-9.4%) |
| Sep 2006 | - | -$16.00M(-7.5%) | -$56.05M(-10.4%) |
| Jun 2006 | - | -$14.89M(-10.6%) | -$50.78M(-8.1%) |
| Mar 2006 | - | -$13.47M(-15.2%) | -$46.99M(-5.3%) |
| Dec 2005 | -$44.63M(-16.1%) | -$11.70M(-9.0%) | -$44.63M(+1.3%) |
| Sep 2005 | - | -$10.73M(+3.4%) | -$45.23M(-0.2%) |
| Jun 2005 | - | -$11.10M(+0.1%) | -$45.15M(-3.6%) |
| Mar 2005 | - | -$11.11M(+9.6%) | -$43.57M(-13.4%) |
| Dec 2004 | -$38.43M(-17.9%) | -$12.29M(-15.3%) | -$38.43M(+42.3%) |
| Sep 2004 | - | -$10.65M(-11.9%) | -$66.67M(-24.9%) |
| Jun 2004 | - | -$9.52M(-59.5%) | -$53.37M(-9.9%) |
| Mar 2004 | - | -$5.97M(+85.3%) | -$48.58M(-2.0%) |
| Dec 2003 | -$32.59M(-35.9%) | -$40.52M(-1632.6%) | -$47.62M(-571.1%) |
| Sep 2003 | - | $2.64M(+155.9%) | -$7.09M(+27.1%) |
| Jun 2003 | - | -$4.73M(+5.5%) | -$9.74M(-94.5%) |
| Mar 2003 | - | -$5.01M | -$5.01M |
| Dec 2002 | -$23.98M(-30.4%) | - | - |
| Dec 2001 | -$18.39M(-33.3%) | - | - |
| Dec 2000 | -$13.79M | - | - |
FAQ
- What is Cytokinetics, Incorporated annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated annual EBIT year-on-year change?
- What is Cytokinetics, Incorporated quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated quarterly EBIT year-on-year change?
- What is Cytokinetics, Incorporated TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated TTM EBIT year-on-year change?
What is Cytokinetics, Incorporated annual earnings before interest & taxes?
The current annual EBIT of CYTK is -$503.01M
What is the all-time high annual EBIT for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high annual earnings before interest & taxes is $25.10M
What is Cytokinetics, Incorporated annual EBIT year-on-year change?
Over the past year, CYTK annual earnings before interest & taxes has changed by -$34.44M (-7.35%)
What is Cytokinetics, Incorporated quarterly earnings before interest & taxes?
The current quarterly EBIT of CYTK is -$166.75M
What is the all-time high quarterly EBIT for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high quarterly earnings before interest & taxes is $57.60M
What is Cytokinetics, Incorporated quarterly EBIT year-on-year change?
Over the past year, CYTK quarterly earnings before interest & taxes has changed by -$25.95M (-18.43%)
What is Cytokinetics, Incorporated TTM earnings before interest & taxes?
The current TTM EBIT of CYTK is -$572.93M
What is the all-time high TTM EBIT for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high TTM earnings before interest & taxes is $27.31M
What is Cytokinetics, Incorporated TTM EBIT year-on-year change?
Over the past year, CYTK TTM earnings before interest & taxes has changed by -$48.31M (-9.21%)